For decades, CVS has been more than just a place to fill a prescription. It has been the stop on the way home from work, the fluorescent-lit refuge when a child wakes up with a fever, the place where a grandmother picks up her blood pressure medicine while grabbing a pack of gum and a greeting card. Behind the scenes, though, CVS Health grew into something far bigger than a neighborhood drugstore. It became a massive healthcare machine, owning not only thousands of retail stores but also one of the country’s largest pharmacy benefit managers, Caremark, and one of the biggest health insurers, Aetna. Now, in a monumental shift, the company has announced that by 2028 it plans to break itself apart, spinning off its pharmacies into a separate new company while keeping its insurance and pharmacy benefits operations together under one roof. It is a decision that will ripple far beyond boardrooms and shareholder calls, touching the lives of customers who rely on their local pharmacy, employees who have built careers there, and patients who simply want their prescriptions covered without a confusing phone call to an insurance help line.
To understand why CVS is doing this, it helps to look at the tangled story of how the company got so large in the first place. What started in 1963 as a Massachusetts discount health and beauty store evolved into a retail pharmacy giant with tens of thousands of locations. Then, as the healthcare landscape changed, CVS decided it wanted to control every step of the patient’s journey. It bought Caremark, a company that manages prescription drug benefits for employers and insurers, in 2007, and then it made an even bigger bet by acquiring Aetna, a major health insurer, in 2018. The idea was beautiful in theory: Aetna would bring in insured members, Caremark would decide which drugs were covered, and the retail stores would fill the prescriptions. It would be a complete, vertical healthcare experience. But the reality proved messier. The retail side faced crushing pressure from falling reimbursement rates, the rise of online shopping, and competition from Amazon and Walmart. Pharmacy staff were stretched thin, often managing more tasks than ever while dealing with angry customers whose insurance denied coverage. The various parts of the corporation did not always work together as one happy family; they were more like separate worlds sharing a name. Investors grew impatient, and the company saw its stock price stumble. Breaking up the massive conglomerate became a way to give each part a better chance to succeed on its own.
When the split happens, the new standalone pharmacy company will take the retail stores, including the pharmacies that operate inside neighborhoods, strip malls, and urban centers across America. It will be a smaller, more focused business, free from the enormous pressures and bureaucracy of the parent company. Meanwhile, CVS Health will keep the insurance and pharmacy benefit management businesses together, forming a leaner organization that can concentrate on negotiating drug prices, managing prescription lists, and providing healthcare coverage. The choice to keep insurance and pharmacy benefits together is important because those two functions are deeply connected. Insurance companies need pharmacy benefit managers to keep drug costs down, and pharmacy benefit managers need insurance companies to give them bargaining power. Together, they form a powerful engine for controlling what medications people get and how much they pay. But separating the pharmacies makes sense because the challenges of running a retail store are wildly different from the challenges of running an insurance company. A retail pharmacy is about foot traffic, staffing shifts, inventory, and customer service. An insurance company is about risk pools, actuarial predictions, network negotiations, and claims processing. Trying to force all of it under one corporate roof was like asking a marathon runner to carry a piano on their back. The split lets both sides move faster, respond to their own customers, and focus on what they do best.
For everyday people, this corporate restructuring is not just a distant financial headline; it is a story about access, trust, and care. Imagine an elderly widow living alone, who visits the CVS at the end of her street every month not only to pick up her heart medication but also to ask the pharmacist about a new symptom. That pharmacist knows her name and her medications. He catches problems, talks to her doctor, and offers a familiar face in a lonely month. What happens to that relationship when the pharmacy is spun off into a new company? For many patients, their loyalty is to their pharmacist, not to the corporate giant. But change is still unsettling. There will be new management structures, new computer systems, and possibly new decisions about which stores stay open and which ones close. Pharmacy workers, already dealing with burnout, will face a period of uncertainty. They might worry about their benefits, their job security, and whether the new company will have the same commitment to serving underinsured communities. And for patients, there is always the fear that the split could make things more complicated rather than simpler. They might have to navigate a phone tree where the insurance arm sends them to the pharmacy arm, and the pharmacy arm sends them back to the insurance arm. Corporate efficiency does not always translate into personal comfort.
The broader healthcare industry will be watching this split closely because it represents a turning point in how we think about vertical integration. For years, the prevailing wisdom was that bigger is better, that joining hospitals, insurers, doctor groups, pharmacies, and pharmacy benefit managers would create savings, better health outcomes, and smoother customer experiences. But the CVS announcement is an admission that bigger can also mean slower, more complicated, and more fragile. Other companies may follow suit, rethinking whether they truly need to own every piece of the healthcare puzzle. This could lead to a wave of divestitures, mergers, and restructurings across the industry. It also raises questions about the future of pharmacy care. If the retail pharmacies become a separate, publicly traded company, they will have to stand on their own financially. That could push them to cut costs, renegotiate contracts, and maybe even close underperforming stores. In rural areas and low-income neighborhoods, where pharmacy access is already limited, that would be a painful consequence. On the other hand, a more focused pharmacy company might be able to innovate, partnering with telehealth providers, offering new clinical services, and building a more efficient supply chain. It could become a nimble partner, not a lost division inside a giant bureaucracy. The truth is, no one knows exactly how it will play out. Healthcare is deeply personal and deeply local, and every corporate decision lands on the shoulders of real people, real families, and real communities.
At its heart, this 2028 breakup is an acknowledgement that the healthcare system has become too tangled for its own good. CVS Health tried to be a one-stop shop for all healthcare needs, but in doing so, it created a maze that was difficult for both patients and executives to navigate. By splitting the retail pharmacies into a new company while keeping insurance and pharmacy benefits together, the company is hoping to make itself easier to understand, easier to manage, and easier to serve customers. But the most important measure of success will not be found in stock charts or quarterly earnings. It will be found in that elderly woman standing at the pharmacy counter, asking if her prescription is ready. It will be found in a young parents’ relief when a pharmacist explains that a cough syrup is safe for their toddler. It will be found in the trust that connects a pharmacist, a patient, and a community. If the new companies can preserve that human connection while becoming more efficient, the breakup will have been worth it. If they cannot, all the restructuring in the world will not heal a system that needs less corporate ambition and more genuine, compassionate care. For now, the announcement is just a plan, and plans can change. But the direction is clear: after years of growing bigger, CVS is choosing to grow simpler. And in a system as complex and exhausting as American healthcare, simplicity may be the greatest gift of all.
